print small large

This application is a service of the Singapore Government.

Health Sciences Authority

Updates on Reclassified Medicines

10 Nov 2017 Nizoral (ketoconazole) cream 2% has been reclassified from P to GSL. 
8 Nov 2017 Kenhancer (ketoprofen) plaster (SIN10769P)has been reclassified from P to GSL.
13 Oct 2017  Fluimucil A Effervescent Tablet 600mg(OTC pack)(SIN15339P ) and Fluimucil Granules 100mg/sachet (OTC pack) (SIN15340P ) have been registered as GSL medicines. For more information on the products, please access HSA Infosearch.
9 Oct 2017 Rhinathiol (carbocisteine) syrup 5% and 2% have been reclassified from P to GSL.
28 Sept 2017 Aleve (naproxen) Tablet 220mg has been reclassified from P to GSL
18 Sept 2017 Xyzal (levocetirizine) Tablet 5mg  has been reclassified from POM to P
4 Aug 2017 Update on preparations which may be reclassified as General Sale List (GSL) under specified conditions. Please click here for details 
11 July 2017 Nurofen (ibuprofen) syrup 100mg/5ml (SIN11880P) has been reclassified from P to GSL. 
10 July 2017 Amorolfine Nail Lacquer 5% (SIN14604P) has been reclassified from P to GSL
3 July 2017 Loceryl (amorolfine) Nail Lacquer 5% (SIN07506P) has been reclassfied from P to GSL.
22 June 2017 Acustop (Flurbiprofen) Cataplasma Plaster 40mg/sheet (SIN12090P) has been reclassified from POM to P. 
1 June 2017

New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 June 2017)

Active ingredient Exemptions for supply of POM without prescription
Alcaftadine

As eyedrops not exceeding 0.25%

Indication: Prevention of itching associated with allergic conjunctivitis

Maximum daily dose: One drop into affected eye once daily

Maximum supply: 3ml

Minimum age: 3 years

Emedastine

As eyedrops not exceeding 0.05%

Indication: Short-term treatment of signs and symptoms of allergic conjunctivitis

Maximum daily dose: One drop into the affected eye twice daily

Maximum supply: 5ml

Minimum age: 3 years

Fexofenadine

As an oral liquid preparation not exceeding 6mg/ml

Indications: For the symptomatic treatment of allergic rhinitis and chronic idiopathic urticarial

Maximum daily dose: 60mg

Maximum supply: 150ml

Minimum age: 2 years

Fluticasone Furoate

As an intranasal spray not exceeding 27.5 mcg/actuation

Indication: Prevention and treatment of allergic rhinitis

Maximum daily dose: 110 mcg

Maximum supply: 3 months

Minimum age: 18 years

Ketotifen

As an oral solid preparation not exceeding 2mg

Indications: Symptomatic treatment of allergic rhinitis and chronic urticaria

Maximum daily dose: 2mg

Maximum supply: 10 days

Minimum age: 3 years

As an oral liquid preparation not exceeding 1mg/5ml

Indications: Symptomatic treatment of allergic rhinitis and chronic urticaria

Maximum daily dose: 2mg

Maximum supply: 120ml

Minimum age: 3 years

Triamcinolone

As a topical paste/lotion containing not more than 0.1%

Indication: For the treatment of mouth ulcers

 

8 May 2017 Loradine (loratadine) syrup 1mg/ml (SIN13341P)has been reclassified from P to GSL.
18 March 2017 Kefentech (ketoprofen) Air Plaster 30mg/sheet (SIN15212P) has been registered as a GSL medicine. 
1 March 2017 Update on preparations which may be reclassified as General Sale List (GSL) under specified conditions. Please click here for details 
23 Jan 2017 Omesec (omeprazole) Capsule 20mg (Pharmacy Only) (SIN15166P) has been registered as a P medicine (14's pack) 
21 Dec 2016 Simtec (cetirizine) Tablet 10mg (OTC) (SIN15142P) has been registered as a GSL medicine (10's pack).
1 Dec 2016

New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 Dec 2016)

Active ingredient Exemptions for supply of POM without prescription

Mometasone
As an intranasal spray not exceeding 50mcg/actuation
  • Indication: Prevention and treatment of allergic rhinitis
  • Maximum daily dose: 200mcg
  • Maximum supply: 3 months
  • Minimum age: 18 years
Esomeprazole As an oral solid preparation not exceeding 20mg
  • Indication: Relief of heartburn symptoms associated with acid reflux
  • Maximum daily dose: 20mg
  • Maximum supply: 2 weeks
  • Minimum age: 18 years

Olopatadine

0.1% and 0.2%

 

As an eyedrop not exceeding 0.2%
  • Indication: Short-term treatment of symptoms of allergic conjunctivitis
  • Maximum daily dose:
    0.1%: One drop in each affected eye two times per day
    0.2%: One drop in each affected eye once a day
  • Maximum supply:
    0.1%: 5ml
    0.2%: 2.5ml
  • Minimum age: 3 years
Ruscogenins and trimebutine

As a rectal cream not exceeding 0.5g/5.8g per 100g

  • Indication: For the symptomatic relief of external and internal haemorrhoids, anal pruritis, anal fissure
  • Maximum daily dose: One or two applications per day
  • Maximum supply: 20g
  • Minimum age: 18 years

As suppositories not exceeding 10mg/120mg

  • Indication: For the symptomatic relief of external and internal haemorrhoids, anal pruritis, anal fissure
  • Maximum daily dose: One to two suppositories per day
  • Maximum supply: 10 suppositories
  • Minimum age: 18 years

 

13 Oct 2016 Neurobion Tablet (OTC) has been registered as a GSL medicine with revised indication and labelling. For more information on this product, please access HSA Infosearch.
13 Oct 2016 Update on preparations which may be reclassified as General Sale List (GSL) under specified conditions. Please click here for details 
22 Sep 2016 Nurofen (ibuprofen)Express Liquid Capsule 200mg and Nurofen (ibuprofen lysine) Express Caplets 342mg have been reclassified from P to GSL. This is a product-specific reclassification.
17 June 2016 Nurofen (ibuprofen) Tablet 200mg (SIN09488P) has been reclassified from P to GSL. This is a product-specific reclassification.
1 June 2016

The following products have been reclassified from P to GSL with effect from 1 June 2016:

  • Eyedrops for relief of redness and/or allergic conjunctivitis containing antihistamines and sympathomimetics
  • Topical scalp treatments containing ketoconazole for dandruff and fungal infections
  • Topical preparations containing up to minoxidil 5%for hair loss

Please click here for the full list of affected products.

3 May 2016 Strepsils MaxPro(flurbiprofen) Honey and Lemon Lozenges 8.75mg has been reclassified from POM to P.
31 March 2016

New POMs granted exemptions for limited sale and supply without prescription (with effect from 31 Mar 2016)

Active ingredient Exemptions for supply of POM without prescription

Betamethasone
As a topical preparation (as valerate or dipropionate salt) as a single agent not exceeding 0.1%
  • Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema
  • Maximum daily dose: Apply to affected areas twice daily
  • Maximum supply: 15g for cream/ointment/gel; 30ml for topical solution
  • Minimum age: 18 years
Mometasone furoate

As a topical preparation as a single agent not exceeding 0.1%

  • Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema.
  • Maximum daily dose: Apply to the affected areas once daily
  • Maximum supply: 15g for cream/ointment/gel;30ml for topical solution
  • Minimum age: 18 years

Triamcinolone acetonide

 

As a topical preparation as a single agent not exceeding 0.1%

  • Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema.
  • Maximum daily dose: Apply to the affected areas twice daily
  • Maximum supply: 15g for cream/ointment/gel;30ml for topical solution
  • Minimum age: 18 years

Adapalene

 

As a topical preparation not exceeding 0.1%

  • Indication: Treatment of acne vulgaris
  • Maximum daily dose: Apply to the affected areas once daily
  • Maximum supply: 30g
  • Minimum age: 12 years
Clindamycin

As a topical preparation not exceeding 1%

  • Indication: Treatment of acne vulgaris
  • Maximum daily dose: Apply to the affected areas twice daily*
*Once daily for fixed combination products containing topical clindamycin not exceeding 1% and benzoyl peroxide
  • Maximum supply: 30g for gel;30ml for topical solution/lotion
  • Minimum age: 12 years
Erythromycin

As a topical preparation not exceeding 4%

  • Indication: Treatment of acne vulgaris
  • Maximum daily dose: Apply to the affected areas twice daily
  • Maximum supply: 30g for gel;30ml for topical solution/lotion
  • Minimum age: 12 years

 

20 Jan 16

2016 reclassification initiatives and request for proposals for medicines to be reclassified by healthcare professionals and industry stakeholders.

Click here for more information.

 

30    Oct 2015 Zyrtec-R (cetirizine) 10mg tablet has been approved as a GSL medicine. The pack size is restricted to 10's only. Please access the Online Infosearch for more information.
12 May 2015 Telfast 120mg Tablet has been reclassified from P to GSL
1 April 2015

New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 April 2015)

Active ingredient Exemptions for supply of POM without prescription
Nystatin

As an oral liquid preparation containing not more than 100,000 units per ml

  • Indication: Treatment of Oral Candidiasis
  • Maximum daily dose:
         Infants and children 6 months and older: 400,000 units
         Adults: 2.4 million units
  • Maximum supply: 2 weeks
  • Minimum age: 6 months

 

 

11 Aug 2014 A list of contrast media injections will be reclassified from GSL to POM with effect from 11 Aug 2014. Please refer to the FAQs and list of products here.
17 June 2014 Clarityne (loratadine) syrup 5mg/5ml has been reclassified from P to GSL under the new brand name of Clarityn syrup. This is a product-specific reclassification.
8 May 2014 Nurofen (Ibuprofen)Tablet 200mg has been reclassified from POM to P.
5 May 2014 A list of contrast media injections will be reclassified from GSL to POM with effect from 11 Aug 2014. Please refer to the list here.  
26 March 2014

The following have been reclassified from P to GSL:

  • Voren (diclofenac)Gel 10mg/g
  • Remethan (diclofenac) Gel 1%
5 March 2014 Tinalite (tolnaftate) 1% cream has been reclassified from P to GSL.
1 Jan 2014 New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 Jan 2014) 

Active Ingredient Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)
Pantoprazole 20mg

As an oral solid preparation containing not more than 20mg

  • Indication: For the relief of heartburn symptoms associated with acid reflux
  • Maximum daily dose: 20mg 
  • Maximum supply: 14 days 
  • Minimum age: 18 years
Omeprazole The PIL for Omeprazole has been updated
2 Sept 2013 Voren Plus Gel (diclofenac) 10mg/g has been reclassified from P to GSL
22 Aug 2013 Uniren (diclofenac) Gel 1% has been reclassified from P to GSL
1 July 2013 New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 July 2013)

Active Ingredient Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)
Fexofenadine 180mg

As an oral solid preparation containing not more than 180mg

  • Indication: For the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria
  • Maximum daily dose: 180mg 
  • Maximum supply: 10 tablets
  • Minimum age: 12 years
11 January 2013

The following products containing codeine have been reclassified from P to POM.

  1. L.T.R Cough Linctus 10mg/5ml (SIN03699P)
  2. Codeine Tablets 30mg (SIN07044P)

Please refer to the Online Infosearch for more information.

1 January 2013 New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 Jan 2013)

Active Ingredient Exemptions for supply of POM without prescription (Active ingredient remains as POM if these criteria are not met)
Desonide

As a topical cream or lotion preparation containing not more than 0.05% w/w

  • Indication: Treatment of redness, swelling and itching that is associated with minor skin ailments such as eczema.
  • Maximum daily dose: 2 to 3 times daily depending on severity.
  • Maximum supply: 15g (cream) or 60ml (lotion)
  • Minimum age: 18 years
Fluconazole As an oral preparation containing 150mg
  • Indications: Vaginal Candidiasis
  • Maximum daily dose: 150mg
  • Maximum supply: 1 tablet
  • Mininum age: 16 years. Not recommended in adults older than 60 years of age
The exemptions for limited sale and supply without prescription for Fexofenadine/Pseudoephedrine have been removed as there are currently no such preparations registered as POM.

Click here for earlier updates